Your browser doesn't support javascript.
loading
An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin.
Snell, Daniel; Gunde, Tea; Warmuth, Stefan; Chatterjee, Bithi; Brock, Matthias; Hess, Christian; Johansson, Maria; Simonin, Alexandre; Spiga, Fabio Mario; Weinert, Christopher; Kirk, Niels; Bassler, Nicole; Campos Carrascosa, Lucia; Flückiger, Naomi; Heiz, Robin; Wagen, Sandro; Giezendanner, Noreen; Alberti, Alessandra; Yaman, Yasemin; Mahler, Dana; Diem, Dania; Lichtlen, Peter; Urech, David.
Afiliação
  • Snell D; Numab Therapeutics AG, Horgen, Switzerland.
  • Gunde T; Numab Therapeutics AG, Horgen, Switzerland.
  • Warmuth S; Numab Therapeutics AG, Horgen, Switzerland.
  • Chatterjee B; Numab Therapeutics AG, Horgen, Switzerland.
  • Brock M; Numab Therapeutics AG, Horgen, Switzerland.
  • Hess C; Numab Therapeutics AG, Horgen, Switzerland.
  • Johansson M; Numab Therapeutics AG, Horgen, Switzerland.
  • Simonin A; Numab Therapeutics AG, Horgen, Switzerland.
  • Spiga FM; Numab Therapeutics AG, Horgen, Switzerland.
  • Weinert C; Numab Therapeutics AG, Horgen, Switzerland.
  • Kirk N; Numab Therapeutics AG, Horgen, Switzerland.
  • Bassler N; Numab Therapeutics AG, Horgen, Switzerland.
  • Campos Carrascosa L; Numab Therapeutics AG, Horgen, Switzerland.
  • Flückiger N; Numab Therapeutics AG, Horgen, Switzerland.
  • Heiz R; Numab Therapeutics AG, Horgen, Switzerland.
  • Wagen S; Numab Therapeutics AG, Horgen, Switzerland.
  • Giezendanner N; Numab Therapeutics AG, Horgen, Switzerland.
  • Alberti A; Numab Therapeutics AG, Horgen, Switzerland.
  • Yaman Y; Numab Therapeutics AG, Horgen, Switzerland.
  • Mahler D; Numab Therapeutics AG, Horgen, Switzerland.
  • Diem D; Numab Therapeutics AG, Horgen, Switzerland.
  • Lichtlen P; Numab Therapeutics AG, Horgen, Switzerland.
  • Urech D; Numab Therapeutics AG, Horgen, Switzerland.
Oncoimmunology ; 12(1): 2233401, 2023.
Article em En | MEDLINE | ID: mdl-37456982
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mesotelina / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mesotelina / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article